Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Precision Oncology Clinical Diagnostic Study In Primary and Metastatic Breast Cancer (PRISM)

NCT07425002 is registered in ClinicalTrials.gov with Cancer Trials Ireland as lead sponsor.

NCT NCT07425002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07425002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Precision Oncology Clinical Diagnostic Study In Primary and Metastatic Breast Cancer (PRISM)
Lead sponsor
Cancer Trials Ireland
Phase
Not applicable
Overall status
Recruiting
Start date
November 11, 2025
Completion date
December 30, 2030
Enrollment
1,600 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer